ConductScience.org, home

Paper41003568

Prevalence and Screening Rates of Hepatitis B and Hepatitis C Infections in Adult Patients with Solitary Organ Tumors.

Abakay S and 6 others. Trop Med Infect Dis, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Prevalence and Screening Rates of Hepatitis B and Hepatitis C Infections in Adult Patients with Solitary Organ Tumors. Papers, record 41003568. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41003568

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prevalence and Screening Rates of Hepatitis B and Hepatitis C Infections in Adult Patients with Solitary Organ Tumors.
PubMed
Journal
Trop Med Infect Dis
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-09-29
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Abakay SSeyhmus
2Döngelli HHüseyinhttps://orcid.org/0000-0003-4032-9209
3Danış NNilayhttps://orcid.org/0000-0002-3939-3089
4Ellez HİHalil İbrahimhttps://orcid.org/0000-0002-9593-0942
5Bengi GGöksel
6Yavuzşen TTuğba
7Semiz HSHüseyin Salihhttps://orcid.org/0000-0002-7083-8517

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126231459Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.Lancet2015https://conductscience.org/library/papers/26231459PubMed
224209764Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center.BMC Cancer2013https://conductscience.org/library/papers/24209764PubMed
336764320Global reporting of progress towards elimination of hepatitis B and hepatitis C.Lancet Gastroenterol Hepatol2023https://conductscience.org/library/papers/36764320PubMed
434427860APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.Hepatol Int2021https://conductscience.org/library/papers/34427860PubMed
525447850American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.Gastroenterology2015https://conductscience.org/library/papers/25447850PubMed
632716741Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.J Clin Oncol2020https://conductscience.org/library/papers/32716741PubMed
726595058Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy: A Systematic Review and Meta-analysis.Ann Intern Med2016https://conductscience.org/library/papers/26595058PubMed
826694960Prevalence of hepatitis B and C and sensibility of a selective screening questionnaire in patients receiving chemotherapy for solid tumors.BMC Cancer2015https://conductscience.org/library/papers/26694960PubMed
919814747Screening for hepatitis B in chemotherapy patients: survey of current oncology practices.Aliment Pharmacol Ther2010https://conductscience.org/library/papers/19814747PubMed
1030249902Hepatitis B and C rates are significantly increased in certain solid tumors: A large retrospective study.J Cancer Res Ther2018https://conductscience.org/library/papers/30249902PubMed
1135576953Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.Lancet Gastroenterol Hepatol2022https://conductscience.org/library/papers/35576953PubMed
1226566064AASLD guidelines for treatment of chronic hepatitis B.Hepatology2016https://conductscience.org/library/papers/26566064PubMed
1325251832HIV and the spectrum of human disease.J Pathol2015https://conductscience.org/library/papers/25251832PubMed
1426163105Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study.Clin Microbiol Infect2015https://conductscience.org/library/papers/26163105PubMed
1518802412Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.MMWR Recomm Rep2008https://conductscience.org/library/papers/18802412PubMed
1639863345AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals.Gastroenterology2025https://conductscience.org/library/papers/39863345PubMed
1733094590Hepatitis B Reactivation in HBsAg-negative Anti-HBc-positive patients receiving cytotoxic chemotherapy for solid tumors.Acta Gastroenterol Belg2020https://conductscience.org/library/papers/33094590PubMed
1832423719Human Immunodeficiency Virus in Adolescents: Risk, Prevention, Screening, and Treatment.Prim Care2020https://conductscience.org/library/papers/32423719PubMed
1932395244Reactivation of Hepatitis B Virus: A Review of Clinical Guidelines.Clin Liver Dis (Hoboken)2020https://conductscience.org/library/papers/32395244PubMed
2023749673Immunosuppression and HBV reactivation.Semin Liver Dis2013https://conductscience.org/library/papers/23749673PubMed

See all 21 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41003568

GET https://conductscience.org/api/papers/v1/41003568/references?page=2